Literature DB >> 23284561

Evaluation of some biochemical markers as prognostic factors in malignant lymphoma.

Hisham Ismail, Mohamed A Soliman.   

Abstract

Entities:  

Year:  2011        PMID： 23284561      PMCID： PMC3533343     

Source DB:  PubMed          Journal:  Int J Health Sci (Qassim)        ISSN： 1658-3639


× No keyword cloud information.
  5 in total

1.  High serum soluble CD44 is correlated with a poor outcome of aggressive non-Hodgkin's lymphoma.

Authors:  Nozomi Niitsu; Kimiko Iijima
Journal:  Leuk Res       Date:  2002-03       Impact factor: 3.156

2.  CD44 variant exons in leukemia and lymphoma.

Authors:  Elif Akisik; Sevil Bavbek; Nejat Dalay
Journal:  Pathol Oncol Res       Date:  2002       Impact factor: 3.201

3.  Hepatitis C Virus and related changes in immunological parameters in non Hodgkin's lymphoma patients.

Authors:  Hanaa M Alam el-Din; Mohammed A Attia; Mohammed R Hamza; Hussien M Khaled; M Abdel-Hamid Thoraya; Sohair A Eisa
Journal:  Egypt J Immunol       Date:  2004

4.  Serum-soluble tumor necrosis factor receptor 2 (sTNF-R2) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma.

Authors:  Naoe Goto; Hisashi Tsurumi; Masao Takemura; Takeshi Hara; Michio Sawada; Senji Kasahara; Nobuhiro Kanemura; Toshiki Yamada; Masahito Shimizu; Takeshi Takahashi; Eiichi Tomita; Mitsuru Seishima; Tsuyoshi Takami; Hisataka Moriwaki
Journal:  Eur J Haematol       Date:  2006-07-19       Impact factor: 2.997

5.  Expression of CD44 and CD44v6 in primary cutaneous CD30 positive T-cell lymphoproliferative disorders.

Authors:  Xiayuan Liang; Bruce R Smoller; Loren E Golitz
Journal:  J Cutan Pathol       Date:  2002-09       Impact factor: 1.587
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.